Text Module


Share

Program Content

Activities

  • AEs With ICI/Targeted Tx
    Expert Strategies for Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2023

    Expires: May 24, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Eisai, Merck Sharp & Dohme LLC, and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Eisai

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc